CONCORD BIOTECH LIMITED (CONCORDBIO) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology.[1]
Concord Biotech Limited
CONCORDBIO
Market Cap₹13,064Cr.
Current Price₹1,248
High / Low₹1,952/987
Stock P/E54.2
Book Value₹193
Dividend Yield0.60%
ROCE17.4%
ROE12.6%
Face Value₹1.00
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 21:44:52